WELLINGTON MANAGEMENT GROUP LLP - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2022$36,428,000
-15.8%
11,383,7210.0%0.01%
-11.1%
Q2 2022$43,258,000
-29.5%
11,383,7210.0%0.01%
-18.2%
Q1 2022$61,358,000
-60.1%
11,383,7210.0%0.01%
-56.0%
Q4 2021$153,794,000
-24.8%
11,383,7210.0%0.02%
-28.6%
Q3 2021$204,452,000
+4.7%
11,383,7210.0%0.04%
+6.1%
Q2 2021$195,345,000
-14.2%
11,383,7210.0%0.03%
-17.5%
Q1 2021$227,674,0000.0%11,383,721
-15.0%
0.04%
-4.8%
Q4 2020$227,674,000
-9.4%
13,392,612
-11.6%
0.04%
-19.2%
Q3 2020$251,386,000
-28.4%
15,152,846
+0.0%
0.05%
-33.3%
Q2 2020$350,909,000
+24.8%
15,151,481
-3.8%
0.08%
+5.4%
Q1 2020$281,084,000
-19.5%
15,746,960
-2.6%
0.07%
+1.4%
Q4 2019$349,127,000
+16.2%
16,174,579
-2.0%
0.07%
+7.4%
Q3 2019$300,566,000
-34.9%
16,500,943
+27.1%
0.07%
-33.3%
Q2 2019$461,839,000
+6.0%
12,980,300
+0.1%
0.10%
+3.0%
Q1 2019$435,507,000
+23.3%
12,961,558
+20.7%
0.10%
+12.5%
Q4 2018$353,069,000
-24.8%
10,741,365
+39.4%
0.09%
-11.1%
Q3 2018$469,584,000
+41.0%
7,703,118
+13.0%
0.10%
+33.8%
Q2 2018$332,984,000
-9.8%
6,819,244
+96.3%
0.07%
-11.9%
Q1 2018$369,216,000
+205.7%
3,474,653
+71.8%
0.08%
+211.1%
Q4 2017$120,764,000
+5036.7%
2,022,162
+1233.4%
0.03%
+2600.0%
Q4 2014$2,351,000
+26.5%
151,659
-1.5%
0.00%0.0%
Q3 2014$1,858,000
+27.4%
153,928
+35.4%
0.00%
Q2 2014$1,458,000
+11.2%
113,723
+5.1%
0.00%
Q1 2014$1,311,000108,2000.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2021
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,828,400$89,281,0006.61%
Cormorant Asset Management, LP 1,500,000$73,245,0005.42%
Camber Capital Management LP 2,000,000$97,660,0003.76%
Rhenman & Partners Asset Management AB 617,652$30,160,0003.09%
BRIDGER MANAGEMENT, LLC 1,134,414$55,393,0003.00%
First Light Asset Management, LLC 374,251$18,275,0002.84%
Gs Investments, Inc. 54,000$2,636,820,0001.97%
SABBY MANAGEMENT, LLC 241,922$11,813,0001.82%
QUANTRES ASSET MANAGEMENT Ltd 50,000$2,441,0001.41%
Tibra Equities Europe Ltd 173,183$8,457,0001.27%
View complete list of NEKTAR THERAPEUTICS shareholders